Critical Therapeutics, Inc. Company Profile

01:28 EDT 23rd March 2018 | BioPortfolio

Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to the asthma drug ZYFLO® (zileuton tablets), as well as other formulations of zileuton. ZYFLO is the only 5-lipoxygenase inhibitor approved for marketing by the U.S. Food and Drug Administration and is indicated for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. The Company’s commercialization efforts for ZYFLO are carried out by its 80-person specialty sales force.


60 Westview Street
United States of America


Phone: (781) 402-5700.

News Articles [846 Associated News Articles listed on BioPortfolio]

Adaptimmune Therapeutics (ADAP) & Celsion (CLSN) Critical Contrast

Adaptimmune Therapeutics and Celsion are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation,...

Osiris Therapeutics (OSIR) and Jazz Pharmaceuticals (JAZZ) Critical Comparison

Osiris Therapeutics and Jazz Pharmaceuticals are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, ...

Edge Therapeutics: A Novel Medicinal Delivery To Manage Highly Critical Conditions

Global Blood Therapeutics: Addressing A Sickle That Impedes Critical Cycling

Global Veterinary Therapeutics Market to Mark CAGR of 6.0% Over Next 10 Years - announces publication of its recently generated research report titled, "GlobalVeterinary Therapeutics MarketBy Type (Therapeutics Drugs, Therapeutics Vaccines, Feed Additives The...

Pluristem Therapeutics (PSTI) - Progress continues

Edison Investment Research - Pharmaceutical & healthcare - Pluristem Therapeutics: Pluristem Therapeutics has had a productive FY18 to date. The company is advancing PLX-PAD in its Phase III study of ...

What You Need to Know About Indalo Therapeutics

Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.

Critical Limb Ischemia Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2750

DelveInsight Critical Limb Ischemia Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Critical Limb Ischemia in seven major markets US, France, Germany, Italy, Spain, U...

PubMed Articles [1496 Associated PubMed Articles listed on BioPortfolio]

Successful limb salvage from critical limb ischemia with bilateral variant anatomy of infrapopliteal arteries.

Immunogenicity assessment during the development of protein therapeutics.

Here we provide a critical review of the state of the art with respect to non-clinical assessments of immunogenicity for therapeutic proteins.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

On the glycosylation aspects of biosimilarity.

The recent expiration of several protein therapeutics opened the door for biosimilar development. Biosimilars are biologic medical products that are similar but not identical copies of already-authori...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Clinical Trials [1125 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness

This study will identify the changes in different muscles of patients receiving Extracorporeal Membrane Oxygenation (ECMO) during critical illness and admission to Intensive Care Unit (ICU...

Companies [1960 Associated Companies listed on BioPortfolio]

Critical Therapeutics, Inc.

Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company...

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic di...

Proteon Therapeutics Inc.

Proteon Therapeutics Inc. is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kid...

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based dise...

Proteon Therapeutics, Inc.

Proteon Therapeutics, Inc., is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular di...

More Information about "Critical Therapeutics, Inc." on BioPortfolio

We have published hundreds of Critical Therapeutics, Inc. news stories on BioPortfolio along with dozens of Critical Therapeutics, Inc. Clinical Trials and PubMed Articles about Critical Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Critical Therapeutics, Inc. Companies in our database. You can also find out about relevant Critical Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Corporate Database Quicklinks

Searches Linking to this Company Record